These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10496941)

  • 21. Iron deprivation induces EFG1-mediated hyphal development in Candida albicans without affecting biofilm formation.
    Hameed S; Prasad T; Banerjee D; Chandra A; Mukhopadhyay CK; Goswami SK; Lattif AA; Chandra J; Mukherjee PK; Ghannoum MA; Prasad R
    FEMS Yeast Res; 2008 Aug; 8(5):744-55. PubMed ID: 18547332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydospore formation in Candida albicans and Candida dubliniensis--an enigmatic developmental programme.
    Staib P; Morschhäuser J
    Mycoses; 2007 Jan; 50(1):1-12. PubMed ID: 17302741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Lo HJ; Tseng KY; Kao YY; Tsao MY; Lo HL; Yang YL
    Int J Antimicrob Agents; 2015 Jun; 45(6):617-21. PubMed ID: 25802233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcript profiling of a MAP kinase pathway in C. albicans.
    Huang H; Harcus D; Whiteway M
    Microbiol Res; 2008; 163(4):380-93. PubMed ID: 18467082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target specificity of the Candida albicans Efg1 regulator.
    Lassak T; Schneider E; Bussmann M; Kurtz D; Manak JR; Srikantha T; Soll DR; Ernst JF
    Mol Microbiol; 2011 Nov; 82(3):602-18. PubMed ID: 21923768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia and Temperature Regulated Morphogenesis in Candida albicans.
    Desai PR; van Wijlick L; Kurtz D; Juchimiuk M; Ernst JF
    PLoS Genet; 2015 Aug; 11(8):e1005447. PubMed ID: 26274602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway.
    Fu Y; Ibrahim AS; Sheppard DC; Chen YC; French SW; Cutler JE; Filler SG; Edwards JE
    Mol Microbiol; 2002 Apr; 44(1):61-72. PubMed ID: 11967069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonfilamentous C. albicans mutants are avirulent.
    Lo HJ; Köhler JR; DiDomenico B; Loebenberg D; Cacciapuoti A; Fink GR
    Cell; 1997 Sep; 90(5):939-49. PubMed ID: 9298905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ssn6, an important factor of morphological conversion and virulence in Candida albicans.
    Hwang CS; Oh JH; Huh WK; Yim HS; Kang SO
    Mol Microbiol; 2003 Feb; 47(4):1029-43. PubMed ID: 12581357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive filamentous growth of Candida albicans is promoted by Czf1p-dependent relief of Efg1p-mediated repression.
    Giusani AD; Vinces M; Kumamoto CA
    Genetics; 2002 Apr; 160(4):1749-53. PubMed ID: 11973327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs.
    Felk A; Kretschmar M; Albrecht A; Schaller M; Beinhauer S; Nichterlein T; Sanglard D; Korting HC; Schäfer W; Hube B
    Infect Immun; 2002 Jul; 70(7):3689-700. PubMed ID: 12065511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans.
    Lo HJ; Wang JS; Lin CY; Chen CG; Hsiao TY; Hsu CT; Su CL; Fann MJ; Ching YT; Yang YL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1213-5. PubMed ID: 15728931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The morphogenetic regulator Czf1p is a DNA-binding protein that regulates white opaque switching in Candida albicans.
    Vinces MD; Kumamoto CA
    Microbiology (Reading); 2007 Sep; 153(Pt 9):2877-2884. PubMed ID: 17768232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic control of chlamydospore formation in Candida albicans.
    Nobile CJ; Bruno VM; Richard ML; Davis DA; Mitchell AP
    Microbiology (Reading); 2003 Dec; 149(Pt 12):3629-3637. PubMed ID: 14663094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1.
    Lane S; Zhou S; Pan T; Dai Q; Liu H
    Mol Cell Biol; 2001 Oct; 21(19):6418-28. PubMed ID: 11533231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
    Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
    Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in Candida albicans EFG1 expression enables host-dependent changes in colonizing fungal populations.
    Pierce JV; Kumamoto CA
    mBio; 2012; 3(4):e00117-12. PubMed ID: 22829676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans Double Mutants Lacking both
    Park YN; Pujol C; Wessels DJ; Soll DR
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968010
    [No Abstract]   [Full Text] [Related]  

  • 40. Efg1 directly regulates ACE2 expression to mediate cross talk between the cAMP/PKA and RAM pathways during Candida albicans morphogenesis.
    Saputo S; Kumar A; Krysan DJ
    Eukaryot Cell; 2014 Sep; 13(9):1169-80. PubMed ID: 25001410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.